METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

被引:22
作者
Lin, Chengjie [1 ,2 ,3 ]
Li, Ting [4 ]
Wang, Yan [1 ,2 ,3 ]
Lai, Shihui [1 ,2 ,3 ]
Huang, Yue [1 ,2 ,3 ]
Guo, Zhenyun [1 ,2 ,3 ]
Zhang, Xiang [1 ,2 ,3 ]
Weng, Shangeng [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Affiliated Hosp 1, Fuzhou 350001, Fujian, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Fujian Abdominal Surg Res Inst, Fuzhou 350001, Fujian, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[4] Fujian Med Univ, Fujian Prov Hosp, Dept Oncol, Prov Clin Coll, Fuzhou 350001, Fujian, Peoples R China
关键词
M(6)A; PATHWAY;
D O I
10.1038/s41419-023-05715-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of the present study was to clarify the mechanism of how METTL3 regulated pancreatic ductal adenocarcinoma (PDAC) progression by m6A modification of its downstream target mRNA and signaling pathway. Immunoblotting and qRT-PCR assays was employed to determine the expression levels of METTL3. In situ fluorescence hybridization was conducted to localize the cellular distribution of METTL3 and DEAD-box helicase 23 (DDX23). CCK8, colony formation, EDU incorporation, TUNEL, wound healing and Transwell assays were carried out accordingly to study the viability, proliferation, apoptosis, and mobility of cells under different treatments in vitro. Xenograft and animal lung metastasis experiments were also conducted to study the functional role of METTL3 or DDX23 on tumor growth and lung metastasis in vivo. MeRIP-qPCR and bioinformatical analyses were used to obtain the potential direct targets of METTL3. It was shown that m6A methyltransferase METTL3 was upregulated in PDAC tissues with gemcitabine resistance, and its knockdown sensitized pancreatic cancer cells to chemotherapy. Furthermore, silencing METTL3 remarkably reduced pancreatic cancer cell proliferation, migration, and invasion both in vitro and in vivo. Mechanistically, validation experiments confirmed that DDX23 mRNA was a direct target of METTL3 in YTHDF1-dependent manner. Additionally, DDX23 silence resulted in the suppression of pancreatic cancer cell malignancy and PIAK/Akt signaling inactivation. Strikingly, rescuse experiments demonstrated the inhibitive effects of METTL3 silence on cell phenotypes and gemcitabine resistance were partially reversed by forcibly expressed DDX23. In summary, METTL3 promotes PDAC progression and gemcitabine resistance by modifying DDX23 mRNA m6A methylation and enhancing PI3K/Akt signaling activation. Our findings establish a potential tumor promotive and chemo-resistant role for METTL3/DDX23 axis in PDAC.
引用
收藏
页数:11
相关论文
共 33 条
[1]   Gemcitabine resistance in pancreatic ductal adenocarcinoma [J].
Binenbaum, Yoav ;
Na'ara, Shorook ;
Gil, Ziv .
DRUG RESISTANCE UPDATES, 2015, 23 :55-68
[2]   CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer [J].
Chen, Shi ;
Yang, Can ;
Wang, Zu-Wei ;
Hu, Jian-Fei ;
Pan, Jing-Jing ;
Liao, Cheng-Yu ;
Zhang, Jia-Qiang ;
Chen, Jiang-Zhi ;
Huang, Yi ;
Huang, Long ;
Zhan, Qian ;
Tian, Yi-Feng ;
Shen, Bai-Yong ;
Wang, Yao-Dong .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[3]   Hypothermia protects neurons against ischemia/reperfusion-induced pyroptosis via m6A-mediated activation of PTEN and the PI3K/Akt/GSK-3β signaling pathway [J].
Diao, Meng-Yuan ;
Zhu, Ying ;
Yang, Jing ;
Xi, Shao-Song ;
Wen, Xin ;
Gu, Qiao ;
Hu, Wei .
BRAIN RESEARCH BULLETIN, 2020, 159 :25-31
[4]   Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer [J].
Fang, Kun ;
Qu, Hairong ;
Wang, Jiapei ;
Tang, Desheng ;
Yan, Changsheng ;
Ma, Jiamin ;
Gao, Lei .
FRONTIERS IN GENETICS, 2021, 12
[5]   Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer [J].
Guo, Yongdong ;
Wang, Ronglin ;
Li, Junqiang ;
Song, Yang ;
Min, Jie ;
Zhao, Ting ;
Hua, Lei ;
Shi, Jingjie ;
Zhang, Chao ;
Ma, Peixiang ;
Yang, Cheng ;
Zhu, Liaoliao ;
Gan, Dongxue ;
Li, Shanshan ;
Liu, Xiaonan ;
Su, Haichuan .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[6]   NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response [J].
Hua, Yong-Qiang ;
Zhang, Ke ;
Sheng, Jie ;
Ning, Zhou-Yu ;
Li, Ye ;
Shi, Wei-Dong ;
Liu, Lu-Ming .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[7]   Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c-Myc translation [J].
Huang, Hua ;
Li, Huan ;
Pan, Ruining ;
Wang, Sijia ;
Khan, Aamir Ali ;
Zhao, Yue ;
Zhu, Huiyu ;
Liu, Xinhui .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (01)
[8]   Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer [J].
Huang, Junjie ;
Lok, Veeleah ;
Ngai, Chun Ho ;
Zhang, Lin ;
Yuan, Jinqiu ;
Lao, Xiang Qian ;
Ng, Kelvin ;
Chong, Charing ;
Zheng, Zhi-Jie ;
Wong, Martin C. S. .
GASTROENTEROLOGY, 2021, 160 (03) :744-754
[9]   Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A [J].
Huang, Yushen ;
Chen, Siyun ;
Pang, Lijun ;
Feng, Zhongwen ;
Su, Hongmei ;
Zhu, Wuchang ;
Wei, Jinbin .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 917
[10]   METTL3 promotes oxaliplatin resistance of gastric cancer CD133+stem cells by promoting PARP1 mRNA stability [J].
Li, Huafu ;
Wang, Chunming ;
Lan, Linxiang ;
Yan, Leping ;
Li, Wuguo ;
Evans, Ian ;
Ruiz, E. Josue ;
Su, Qiao ;
Zhao, Guangying ;
Wu, Wenhui ;
Zhang, Haiyong ;
Zhou, Zhijun ;
Hu, Zhenran ;
Chen, Wei ;
Oliveira, Joaquim M. ;
Behrens, Axel ;
Reis, Rui L. ;
Zhang, Changhua .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (03)